Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Gross Profit (2018 - 2025)

Abvc Biopharma (ABVC) has disclosed Gross Profit for 9 consecutive years, with $827729.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 42002.19% year-over-year to $827729.0, compared with a TTM value of $1.3 million through Dec 2025, up 162.49%, and an annual FY2025 reading of $31779.0, down 93.75% over the prior year.
  • Gross Profit was $827729.0 for Q4 2025 at Abvc Biopharma, up from $1966.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $827729.0 in Q4 2025 and bottomed at -$137041.0 in Q4 2023.
  • Average Gross Profit over 5 years is $130648.6, with a median of $31528.0 recorded in 2022.
  • The sharpest move saw Gross Profit plummeted 167.33% in 2021, then surged 42002.19% in 2025.
  • Year by year, Gross Profit stood at -$40595.0 in 2021, then surged by 897.1% to $323583.0 in 2022, then tumbled by 142.35% to -$137041.0 in 2023, then skyrocketed by 101.43% to $1966.0 in 2024, then soared by 42002.19% to $827729.0 in 2025.
  • Business Quant data shows Gross Profit for ABVC at $827729.0 in Q4 2025, $1966.0 in Q4 2024, and $388980.0 in Q3 2024.